SCHEMBL4665671

SCHEMBL4665671

CCc1nn(-c2ncccc2C)c(Nc2ccc(OC(F)(F)F)cc2C(=O)OC)c1Br

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 1/20 0.37
MAPT P10636 2/20 0.37
DHODH Q02127 1/20 0.36
ADORA1 P30542 8/20 0.36
TP53 P04637 2/20 0.36
ADORA3 P0DMS8 1/20 0.35
SCN8A Q9UQD0 1/20 0.35
SCN10A Q9Y5Y9 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
CCR9 P51686 1/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
PDE2A O00408 1/20 0.34
ELANE P08246 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14600195 0.93 DHODH (0.42) P2RY1MAPTDHODHADORA1TP53
SCHEMBL4667054 0.86 ADORA1 (0.40) P2RY1ADORA1ADORA3SCN8ASCN10A
SCHEMBL14600440 0.83 ADORA1 (0.50) DHODHADORA1TP53ADORA3
SCHEMBL14600266 0.83 ADORA1 (0.54) DHODHADORA1ADORA3
SCHEMBL14600672 0.81 ADORA1 (0.46) DHODHADORA1TP53ADORA3
SCHEMBL14600233 0.80 ADORA1 (0.46) DHODHADORA1TP53ADORA3
SCHEMBL14600704 0.80 ADORA1 (0.46) DHODHADORA1TP53ADORA3
SCHEMBL14601006 0.80 ADORA1 (0.49) DHODHADORA1ADORA3
SCHEMBL14600991 0.80 ADORA1 (0.53) DHODHADORA1ADORA3TRPV1
SCHEMBL14601008 0.80 ADORA1 (0.47) DHODHADORA1TP53ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed